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H1N1 Influenza Virus
By: Kail Consford and Drew Patel
Background

Treatment
Infection/Disease

Background
On April 17, 2009, two patients in the United States were found with
Swine-Origin Influenza A (H1N1) virus. This virus was spread to
Mexico, Canada, and many other countries. From April 15 through
May 5, a total of 642 confirmed cases of H1N1 infection were identified
in 41 states. The ages of the patients were from 3 months to 81 years,
and 60% of the patients were 18 or younger. Most of these patients
recently came from either Mexico or even from school outbreaks. The
most common symptoms were fever, cough, and a sore throat. The
H1N1 was determined to have a unique genome composition that had
not been identified previously (Padilla et al., 2009).

Immune response
H1N1 goes through immune response with the three lines of defense.
The first line of defense had goes through a sore throat, runny nose,
and coughing stage. It soon became air born. The second non-specific
line of defense began with a 99.0 F. The third specific line of defense
was developing severe pneumonia. The patients with pneumonia had
no distinguishing epidemiologic, clinical, or laboratory features
(Plennevaux et al., 2009).

Progression
Historical
“Studies performed over the past 15 years have confirmed the
therapeutic benefit of amantadine when given early in the course of
acute illness due to influenza A virus, both in shortening their
symptoms and decreasing their severity. Despite the reports,
amantadine is not used in medicine very often. Clinicians were
concerned about the side effects of amantadine and may be convinced
that other drugs, such as aspirin, are just as effective in relieving
symptoms and controlling fever. During an outbreak of influenza
A/Brazil/78 H1N1 infection in the winter of 1981, a controlled doubleblind study was performed comparing the therapeutic advantages and
disadvantages of amantadine and aspirin for the treatment of
influenza. Low and high doses of amantadine were compared to
determine if side effects could be preventable (Younkinh, Betts, Roth,
& Douglas, 1983).
Microorganism
H1N1 is an influenza virus that is related to the swine flu. Influenza
viruses cause epidemics of respiratory illness and pandemics. Like all
viruses, influenza relies on the host cellular machinery to support their
life cycle. Efforts to control these outbreaks and real-time monitoring
of the evolution of this virus should provide us with invaluable
information to direct infectious disease control programmers and to
improve understanding of the factors that determine viral
pathogenicity and/or transmissibility (Plennevaux et al., 2009).

Doctors used amantadine
to control fevers and relieve
symptoms. Patients without
amantadine increased their
risk in death. Doctors try
to decide whether more doses
of amantadine will prevent the
side effects. They also study the
symptoms to see what else they
need to prevent to find a vaccine
for H1N1 (Padilla et al., 2009).

How the H1N1 cell is
constructed

Prognosis
Mexico had reported 4,910 confirmed cases and 85 deaths caused by
H1N1. Mexico had the most severe H1N1 cases than any other country
and also had the most patients with the virus. Pneumonia was the
worst side effect and the hardest to get rid of. Doctors reviewed
clinical data from patients with influenza-like illnesses and pneumonia
with a negative result on H1N1. They took swabs to study the effects of
medicines so that they could which medicines helped with the
symptoms of H1N1. Once primers and probes were developed, they
sent the vaccines to Mexico to hopefully reduce the cases of h1n1 and
deaths (Ginocchio et al., 2009).

Options
H1N1 can cause illness, respiratory distress syndrome, and death.
Because of these symptoms, this virus is very deadly to all ages.
Doctors came to the conclusion that amantadine would be a necessary
treatment for this virus. Amantadine helps control high fever and
relieves the symptoms of H1N1. Doctors also tried the adding of oiland-water to a TIV but did not increase the frequency of response in
2009. Microneutralization assay was another technique used by the
Centers for Disease Control and Prevention to prove some adults have
serum cross-reactive antibodies to the H1N1 virus. Because of the
results of only one out of 124 children with this antibody at the level of
40, they had an increase to the 2009 H1N1 strain after receipt of
“seasonal trivalent inactivated influenza vaccine” (World Health
Organization, 2010).
Mechanism
Patients began getting doses of medications receiving it at admission (A
mean of 8 days after the onset of symptoms). Each patient was given an
antibiotic to help doctors find witch antibiotic showed the most
improvement. Doctors tried different vaccines for patients that had
different symptoms to see if their symptoms would lesson. After trying
corticosteroids, five out of six patients died. They tried many more
vaccines after they found what was in the corticosteroids that made the
five patients die (Nishiura, 2009).
Emerging
Although antigen based tests require little technical skill, are rapid and
can be performed in an emergency department setting, the sensitivity
and specificity of the assays are questionable. BinaxNOW assay (a
swine-flu test) demonstrated very poor sensitivity for the detection of
both seasonal influenza A compared to R-Mix culture. (Padilla et al.,
2009).

Symptoms and how HlNl
began.
Areas that have been
affected

Presented at the Nacogdoches ISD Board of Trustees meeting February 19, 2015.

References available upon request.

